Search filters

List of works by Carmen Criscitiello

A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer

scientific article published on 04 December 2018

A gene signature of chemo-immunization to predict outcome in patients with triple negative breast cancer treated with neoadjuvant chemotherapy

article

A multidisciplinary approach to an unusual medical case of locally advanced gastric cancer: a case report.

scientific article published on 26 January 2015

A phase II trial of the CDK4/6 inhibitor palbociclib (P) as single agent or in combination with the same endocrine therapy (ET) received prior to disease progression, in patients (pts) with hormone receptor positive (HR+) HER2 negative (HER2−) meta

Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trials.

scientific article published on 27 April 2012

Adjuvant treatment of early male breast cancer

scientific article published on 26 August 2020

Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine.

scientific article published on 12 March 2015

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca

scientific article published on 2 August 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in I

scientific article published in September 2017

Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents

scientific article published on 23 September 2020

Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets

scientific article

Best management of locally advanced inoperable breast cancer

scientific article

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

scientific article

Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review

scientific article

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion

scientific article published on 20 August 2018

Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers.

scientific article

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

scientific article

Cardiotoxicity of systemic agents used in breast cancer

scientific article published on May 2014

Circulating tumor cells and emerging blood biomarkers in breast cancer

scientific article

Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer.

scientific article

Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment

scientific article

Dendritic cell-based vaccines: clinical applications in breast cancer.

scientific article published on January 2014

Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.

scientific article published on August 2013

Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs

scientific article published on 18 June 2019

Dinaciclib for the treatment of breast cancer.

scientific article

ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer

scientific article published on 01 May 2020

Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes

scientific article published on 29 March 2020

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

scientific article

Entinostat for the treatment of breast cancer.

scientific article published on 18 July 2017

Exemestane in the treatment of breast carcinoma: recent findings

scientific article published in January 2008

Expression of tumor-associated antigens in breast cancer subtypes

scientific article published on 12 December 2019

Extending indication of cyclin-dependent kinase 4/6 inhibitors in the adjuvant and neoadjuvant setting

scientific article published in September 2017

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

scientific article

Global cancer control: responding to the growing burden, rising costs and inequalities in access.

scientific article

HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence

scientific article published on July 2016

HER2 Signaling Pathway and Trastuzumab Cardiotoxicity ⬇️

scientific article published on February 1, 2013

HER2-positive circulating tumor cells in breast cancer

scientific article

Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer

scientific article published on 01 November 2019

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.

scientific article published on 4 December 2013

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?

scientific article published on 26 March 2013

Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer.

scientific article

Immune approaches to the treatment of breast cancer, around the corner?

scientific article published on 25 February 2014

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".

scientific article published on 03 March 2014

Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.

scientific article

Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study

scientific article published on 22 June 2015

Immunotherapeutics for breast cancer

scientific article

Immunotherapy of Breast Cancer

scientific article published on 4 September 2015

Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study

scientific article published on 21 October 2020

Impact of autoimmune diseases on outcome of patients with early breast cancer.

scientific article published on 13 June 2016

Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis

scientific article published on 17 May 2018

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medica

scientific article published on 08 August 2019

Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy

scientific article published on 05 March 2014

Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies.

scientific article

Locoregional recurrence in patients with HER2 positive breast cancer

scientific article published in May 2013

Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer

scientific article published on 29 June 2017

Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist

scientific article published on 11 September 2015

Molecular pathways: human leukocyte antigen G (HLA-G).

scientific article published on 29 July 2013

Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities

scientific article published on 23 October 2013

Neoadjuvant Model for Testing Emerging Targeted Therapies in Breast Cancer.

scientific article

No link between breast cancer and meningioma: results from a large monoinstitutional retrospective analysis

scientific article published on 28 October 2013

Optimal adjuvant chemotherapy in breast cancer: selection of agents

scientific article published on August 2014

Over-using chemotherapy in the adjuvant setting

scientific article published on 17 November 2016

PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?

scientific article published on 28 June 2020

Peptide vaccines in early breast cancer

scientific article published on 07 February 2019

Pharmacokinetic drug evaluation of ribociclib for the treatment of metastatic, hormone-positive breast cancer

scientific article published on 11 April 2017

Pharmacological management of male breast cancer

scientific article published on 04 June 2020

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

scientific article published on 16 October 2020

Pre-treatment blood parameters predict efficacy from immunotherapy agents in early phase clinical trials

scientific article published on 12 August 2020

Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer

scientific article published on 11 July 2019

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

scientific article published on 30 January 2018

Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer

scientific article published on 6 October 2016

Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer

scientific article published on 15 November 2017

QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review.

scientific article published on 27 June 2014

RNAi screens identify CHD4 as an essential gene in breast cancer growth

scientific article

Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond

scientific article

Successes and limitations of targeted cancer therapy in breast cancer

scientific article published on 17 February 2014

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

scientific article

Targeted therapies in breast cancer: are heart and vessels also being targeted?

scientific article

Targeting fibroblast growth factor receptor pathway in breast cancer

scientific article published on 22 September 2015

Targeting the subtypes of breast cancer: rethinking investigational drugs

scientific article published on 10 January 2012

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

scientific article published in January 2008

The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.

scientific article published on January 2017

The Impact of Translational Research in Breast Cancer Care: Can We Improve the Therapeutic Scenario?

scientific article published on 2 November 2017

Treatment in real-life patients with HER2-positive metastatic breast cancer: What we learn from the KAMILLA trial?

scientific article published on 21 June 2019

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

scientific article published on 02 July 2016

Tumor-infiltrating lymphocytes (TILs) in ER+/HER2- breast cancer

scientific article published on 03 July 2020

Tumor-stroma crosstalk: targeting stroma in breast cancer.

scientific article

Tumour infiltrating lymphocytes and correlation with response to intensified platinum-based chemotherapy in BRCA-like tumours

scientific article published on 20 January 2020

WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells

scientific article published on 21 November 2019

What have we learned from immunotherapy? Report from the 3rd and 4th meetings of the Campania Society of Oncology Immunotherapy (SCITO).

scientific article

What indication, morbidity and mortality for central pancreatectomy in oncological surgery? A systematic review.

scientific article published on 18 December 2015

Paulina is supported by:

About Paulina

Help